Zevra Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 4.51 M | $40.38 M | 11.64% | 8.06% |
| WOODLINE PARTNERS LP | 02/17/2026 | 3.45 M | $30.92 M | -0.73% | 6.17% |
| VANGUARD GROUP INC | 01/29/2026 | 3.31 M | $29.61 M | 7.19% | 5.91% |
| FMR LLC | 02/17/2026 | 2.39 M | $21.45 M | 46.43% | 4.28% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.77 M | $15.88 M | -10.14% | 3.17% |
| STATE STREET CORP | 02/13/2026 | 1.48 M | $13.29 M | 3.90% | 2.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.34 M | $12.02 M | 3.18% | 2.40% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 1.20 M | $10.76 M | 4.49% | 2.15% |
| MORGAN STANLEY | 02/13/2026 | 1.16 M | $10.37 M | 108.28% | 2.07% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.13 M | $10.16 M | 9.57% | 2.03% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 1.10 M | $9.87 M | 10.11% | 1.97% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 1.10 M | $9.84 M | 4.23% | 1.96% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 905.00 K | $8.11 M | -7.18% | 1.62% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 865.82 K | $7.76 M | 25.26% | 1.55% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 863.75 K | $7.74 M | 19.00% | 1.54% |
| CITADEL ADVISORS LLC | 02/17/2026 | 842.85 K | $7.55 M | 339.45% | 1.51% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 692.10 K | $6.20 M | 54.52% | 1.24% |
| MARSHALL WACE, LLP | 02/13/2026 | 669.74 K | $6.00 M | -26.59% | 1.20% |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 01/28/2026 | 662.98 K | $5.94 M | 10.35% | 1.18% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 588.70 K | $5.27 M | -22.72% | 1.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/17/2026 | 585.07 K | $5.24 M | -9.99% | 1.05% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 569.09 K | $5.10 M | -29.74% | 1.02% |
| JANE STREET GROUP, LLC | 02/12/2026 | 563.91 K | $5.05 M | 163.26% | 1.01% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 540.11 K | $4.84 M | 5.89% | 0.97% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 506.03 K | $4.46 M | 22.66% | 0.90% |
| NORTHERN TRUST CORP | 02/17/2026 | 418.12 K | $3.75 M | -4.86% | 0.75% |
| JPMORGAN CHASE & CO | 02/11/2026 | 412.26 K | $3.69 M | -6.09% | 0.74% |
| STRATOS WEALTH PARTNERS, LTD. | 01/20/2026 | 409.00 K | $3.66 M | 78.60% | 0.73% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 356.24 K | $3.19 M | 16.23% | 0.64% |
| MYSTIC ASSET MANAGEMENT, INC. | 01/28/2026 | 346.53 K | $3.10 M | -0.04% | 0.62% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 317.07 K | $2.84 M | 18.27% | 0.57% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 293.10 K | $2.63 M | -75.69% | 0.52% |
| UBS GROUP AG | 01/29/2026 | 285.49 K | $2.56 M | 30.90% | 0.51% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 275.00 K | $2.46 M | -87.64% | 0.49% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 209.70 K | $1.88 M | -30.76% | 0.37% |
| JANNEY MONTGOMERY SCOTT LLC | 02/11/2026 | 202.88 K | $1.82 M | 10.44% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 197.20 K | $1.77 M | 13.79% | 0.35% |
| TFG ASSET MANAGEMENT GP LTD | 02/17/2026 | 192.52 K | $1.72 M | 100.00% | 0.34% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 181.13 K | $1.62 M | 18.92% | 0.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 180.62 K | $1.62 M | 14.49% | 0.32% |
| KOVACK ADVISORS, INC. | 02/17/2026 | 175.33 K | $1.57 M | 0.03% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 174.16 K | $1.56 M | 38.40% | 0.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 170.31 K | $1.53 M | -9.06% | 0.30% |
| CITADEL ADVISORS LLC | 02/17/2026 | 157.20 K | $1.41 M | 53.97% | 0.28% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 154.47 K | $1.38 M | 100.00% | 0.28% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 151.42 K | $1.36 M | 196.62% | 0.27% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 149.64 K | $1.34 M | 83.45% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 146.36 K | $1.31 M | -49.19% | 0.26% |
| NUVEEN, LLC | 02/12/2026 | 143.13 K | $1.28 M | -6.47% | 0.26% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 139.59 K | $1.25 M | 100.00% | 0.25% |
Zevra Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 197 institutional investors and hedge funds held shares of Zevra Therapeutics Inc. The most heavily invested institutionals were:
AIGH Capital Management LLC: 1.2 M
UBS Group AG: 422,048
Stratos Wealth Partners, LTD.: 408,000
FLPUTNAM INVESTMENT MANAGEMENT CO: 350,501
Janney Montgomery Scott LLC: 236,834
Nuveen, LLC: 192,588
68.18% of Zevra Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 43.22 M shares in the last 24 months. This purchase volume represents approximately $394.13 M in transactions.